Medical Device Supplier – Radioactive Diagnostic Agent

The contract requires the supply of 1,000 PG of a radioactive medical diagnostic agent, packaged in 30 vials per unit, with strict refrigeration requirements between 2–8°C throughout handling and transportation. The product must comply with all federal regulations governing hazardous and radioactive materials, ensuring safe packaging, labeling, and shipping protocols. This is a subcontract under the Department of Defense’s Medical Supply Chain for Military Surgical Facilities, with performance designated to FPO, ZIP 09566-4008, indicating delivery to a military post office location, likely supporting overseas or deployed medical operations. The NAICS code 325412 confirms the classification as pharmaceutical and medicine manufacturing, underscoring the specialized nature of the product and the supplier’s necessary expertise. The solicitation was posted on July 15, 2026, with responses due by July 21, 2026, indicating a tight five-day window for bid submission. The contract is managed through the Defense Logistics Agency’s DIBBS system, with the official RFQ accessible via the provided link, and all suppliers must meet the stringent regulatory and logistical demands associated with radioactive pharmaceuticals. There is no set-aside designation, meaning the opportunity is open to any qualified vendor regardless of business size or status, but compliance with DOT, NRC, and FDA standards for radioactive diagnostics is mandatory. Timely delivery and adherence to cold-chain logistics are critical to maintaining the integrity and usability of the diagnostic agent in clinical settings.